Bain Capital Morrison Foerster advised Bain Capital, the global private investment firm, on its $3.3 billion acquisition of Mitsubishi Tanabe Pharma Corporation, in a carve-out transaction from Mitsubishi Chemical Group Corporation. Mitsubishi Tanabe Pharma was founded in 1678. It is a pharma multinational headquartered in the birthplace of Japan’s pharmaceutical industry, Doshomachi (in Osaka). The carve-out accelerates Mitsubishi Tanabe Pharma’s growth and global expansion and provides access to additional resources through the help of Bain Capital. We believe there are promising signs for growth... in Japan’s life sciences industry [and] look forward to a collaborative partnership with MTPC.” Ricky Sun, Partner, Bain Capital Life Sciences and Masa Suekane, Partner and Head of Japan Healthcare, Industrials and Financial Services, Bain Capital Private Equity 4 Morrison Foerster
RkJQdWJsaXNoZXIy NTU5OTQ5